Exchange: NASDAQ·Updated 04:00 PM EDT
LGVN logo

LGVN Longeveron Inc - Ordinary Shares - Class A

$6.92
$0.41
(5.59%)
Today
EarningsNov 4
Mkt Cap$32.93M
Vol61,879.00

About LGVN

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
45

Neutral Sentiment

How do you feel about LGVN?

Advertisement|Remove ads.